logo

Immunic, Inc (IMUX)



Trade IMUX now with
  Date
  Headline
2/26/2021 7:11:53 AM Immunic FY Loss Per Share $2.81 Vs Loss $4.52 Last Year
2/18/2021 6:40:04 AM Immunic Reports Positive Data From Phase 2 Proof-of-Concept Clinical Trial Of IMU-838 In Primary Sclerosing Cholangitis
2/17/2021 6:54:58 AM Immunic Says IMU-838 Shows Evidence Of Clinical Activity In Hospitalized Patients With Moderate COVID-19
12/14/2020 6:34:21 AM Immunic, Inc. Added To NASDAQ Biotechnology Index
11/17/2020 6:39:21 AM Immunic Announces Formation Of A Scientific-Medical Advisory Board
11/2/2020 6:41:37 AM Immunic Says 200 Patients Enrolled In Phase 2 CALVID-1 Trial Of IMU-838; Expects Top-Line Data In Q1 2021
9/28/2020 6:35:58 AM Immunic Announces Results From Interim Safety Analysis And Recruitment Update From Phase 2 CALVID-1 Trial Of IMU-838
9/11/2020 6:34:37 AM Immunic Publishes Full Unblinded Clinical Data From Phase 2 EMPhASIS Trial Of IMU-838
8/20/2020 6:32:19 AM Immunic Announces Dosing Of First Healthy Volunteer In Phase 1 Clinical Program Of IMU-856
8/10/2020 6:35:50 AM Immunic Announces Closing Of Public Offering Of 5.75 Mln Shares At $18/Shr
8/4/2020 8:44:46 PM Immunic Prices Public Offering Of 5 Mln Shares At $18.00/shr